How will the Indian Pharmaceutical industry be impacted by the 100 per cent tariffs on branded and patented drugs, as announced by US President Donald Trump? Taking to the social media platform Truth Social, he announced tariffs on products like the branded or patented drugs, which are not made in the US and imported into the country. He said that such products will face a 100 per cent tariff starting October 1, 2025. However Trump added that the companies that are building the manufacturing units in the US, would be exempted from this levy. The president clarified that the US firms that are either "breaking ground" and/or "under construction" would be exempted. He added that those who have already started the construction work will not have to pay the additional tariff imposed now.

India

See Full Page